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OUR interest in sarcoma of the uterus has been stimulated by several recent
encounters with the condition. This experience has prompted us to survey and
report a series of cases occurring in this hospital since 1937, following the series
previously reported by Handley and Howkins (1937).
Sarcoma of the uterus has attracted the attention of both clinicians and path-
ologists since Mayer's report in 1861. Papers published since that date have all
recorded small series of cases treated in a variety of ways; they all make depres-
sing reading, as the condition is notoriously difficult to diagnose clinically and
carries a high mortality. We have collected 26 cases, in no way selected, occurring
between the years 1937 and 1950. One case was rejected due to insufficient data,
leaving 25 for study. They came predominantly from the ward practice of a large
general hospital and a small associated special hospital.
It seems to us rather fruitless to try and deduce the frequency with which
uterine sarcomata occur. Suffice it to say that the condition is not common (Perry,
1948), and that our 26 cases occurred in about 20,000 gynaecological admissions.
Many attempts have been made, especially by American contributors, to relate
the number of uterine sarcomata to the number offibromyomata seen (Lynch and
Maxwell, 1931.), orto assess therelativefrequencyofuterine sarcomaand carcinoma
(Donaldson, 1933). In some series the number of sarcomata seen is related to the
total number of uterine tumours (Igna and Mitchell, 1943; Browne, 1950). We
believe that the results of most of these mathematical exercises may be fairly
summed up in the statement that sarcoma of the uterus is a rare condition. It
appears to be generally accepted that not more (and probably a good deal less)
than 1 per cent of uterine fibromyomata undergo sarcomatous change.
The age incidence of our cases is shown in Table I. The youngest was 39 and
the oldest 72 years.
TABLE I.-Age Incidence ofTwenty-five Cases of Uterine Sarcoma.
Age. Number of
(years.) cases.
Up to40 . . 5
41-50 . . 11
51-60 . . 5
Over60 . . . 4
Three ofthese cases were single women; owing to lack ofinformation in several of
the cases it was impossible to assess the influence of parity on the condition; We
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more common in the post-menopausal woman. We encountered only 6 post-
menopausal women in our series, all of whom presented with bleeding as the
dominating symptom, as reference to Table II will show.
TABLE II.-Symptoms ofTwenty-five Cases of Uterine Sarcomnwa.
Number of ~~~~~Symptom. ~cases.
Menorrhagia and/or irregular bleeding . . 12
Post-menopausal bleeding . . . . 6
Abdominal enlargement . . . . . 4
Abdominal pain . . . . . .
Retention of urine . . . . . 1
Diarrhoea and dyspnoea . . . . . 1
(One case presented with both post-menopausal bleeding and abdominal
enlargement.)
These symptoms are common to most series of uterine sarcomata. The case
presenting with acute retention of urine was unusual. The tumour had to be
shelled out of the uterus before it could be freed from the pelvis, and a subtotal
hysterectomy was performed. The patient was unfortunately lost sight of after
the war, but was known to have survived the operation by 7 years.
Thedifficulty ofcorrect pre-operative diagnosis isnotorious, andwill be referred
to again. It is probably true to say that the most suggestive features of a case
would be post-menopausal enlargement of a fibroid, perhaps accompanied by
bleeding.
TABLE III.-Diagnosis ofTwenty-five Cases of Uterine Sarcoma.
~~~~~~~Diagnosis. ~Numberof ~~~~~~~~~~~~Diagnosis. ~cases.
Correct pre-operative diagnosis . . . . . . . . . . 2
Correct diagnosis at laparotomy . . . . . . . . . . 4
Curettage and subsequent histological diagnosis . . . . . . . 5
Laboratory diagnosis after hysterectomy for "fibroids" and menorrhagia . . . 14
It will be seen that the problem ofdiagnosis in these cases is one ofconsiderable
difficulty. Our experience appears to be in close agreement with that of others
(Evans, 1920; Lynch and Maxwell, 1931), and it is worth noting perhaps that
one of our cases correctly diagnosed pre-operatively presented with both post-
menopausal bleeding and abdominal enlargement, a combination that strongly
spggests uterine sarcoma. Schj6tt-Rivers (1949), however, makes the unusual
claim that 75 per cent of uterine sarcomata can be correctly diagnosed pre-
operatively, but then concedes that the common pre-operative diagnosis is one of
fibromyomata, subsequently corrected either at laparotomy or on histological
examination.
Pathology and Prognosis.
A more detailed analysis of these cases is now attempted and certain well
recognised features ofmalignancy are considered, with a view to correlating them
with prognosis.
In most cases there was only one histological section available for study and in
these instances every high-power field (x 485) was examined. Where there was
more than one section available, at least 50 fields were examined in each section.
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It is thus apparent that some cases will have had a more detailed examination
than others, so that a truer picture will be obtained in these cases.
The following features were considered:
I. Relation of tumour cells to blood-vessels.
II. Degree of cellularity.
III. Variability of cell size.
IV. Cellular morphology.
V. Presence ofgiant cells.
VI. Mitosis.
VII. Hyperchromatism.
VIII. Site of origin.
I. Relation of tumour cells to vessels.
The cases were grouped according to whether tumour cells were in contact with
the blood stream. In some cases malignant cells could be seenlying in andinvading
preformed vessels, capillaries and veins, thoughno arterieswere seento beinvolved.
In others the cells were lining blood-filled spaces with only a suggestion of a pre-
formed vessel (Fig. 1), most easily seen in a Van Gieson stained section. In the
remainder there were blood spaces lined purely by tumour cells. The cases falling
into the first two categories were grouped together under the heading "Related to
Blood Vessels." The results are expressed in Table IV.
TABLE IV.-Length of Survival in Cases Related and not Related to Blood-vessels.
Not related to blood-vessels. Related to blood-vessels.
14 years A & W . 18 months D
13 ,, ,, . 10 . ..
12 , ,, . 9 ..
11 ,, ,, 9
11 ,, ,, . 7 . ..
9 , ,, . 4 . ..
8 ,, ,, . 2 ,. ..
8 ,, ,, . 1 ,. ..
7 ,, ,, . 1 ..
7 ,,
3 ,, ,, . 9 cases
3 ,, ,,
1
6 months D
3 ,, ,,
2 years ,,
16 cases
In this and subsequent tables D - Death of the patient from sarcoma of uterus. The time is
that which elapsed between operation and death. A & W = Alive and well. The time is that which
elapsed between operation and when last seen at follow-up clinic.
From Table IV it is seen that all the cases related to blood-vessels died within
a period of 18 months following operation. In the group showing no relationship
to blood vessels, 3 cases died within 2 years of operation. The remaining cases
have survived up to 14 years after diagnosis up to the present time. We thus see
that the relationship of tumour cells to blood-vessels distinguishes the highly
malignant cases from those of lesser malignancy.348 W. JONES WILLIAMS AND G. BANCROFT-LIVINGSTON
II. Degree of cellularity.
Thedegree ofcellularity ofatumouris oftenofassistance as an aidtoprognosis,
since in general the more cells and the less stroma the more malignant is the
tumour. In order to discover if this feature is of value in assessing prognosis in
uterine sarcoma the cases were grouped as follows, according to the proportion of
cells per field as compared to stroma:
Group 1: Lesser degree of cellularity.
Group 2: Medium degree of cellularity.
Group 3 : Greater degree of ce]lularity.
The findings based on the degree of cellularity of the tumour showed no
correlation with length of survival so that a detailed table of the findings is not
included.
III. Variability in cell size.
The degree of variation in cell size in the tumour was expressed as follows:-
Group 1 : Smnall variation in cell size.
Group 2: Moderate variation in cell size.
Group 3: Large variation in cell size (Fig. 2).
The results are expressed in Table V.
TABLE V.-Length ofSurvival and Number ofPatients in each Group.
Group 1. Group 2. Group 3.
A A
14 years A &W . 12 years A &W . 1 year A & W
13 ,, ,, . 7 ,, ,, . 10 months D
11 ,, ,, . 18 months D . 6 ..
11 ,, . ,, . . 9 ,, . ,, . . 2 ,. ..
9 ,, ,, 9
8 ,, ,, . 7 , ,, . 4 cases
8 .... . 1 . ..
7 ,.
3 , ,, . 7 cases
3 ,,
2 5
4 months ,,
3 ,, ,
14 cases
In Group 1 (showing the least variation in cell size), 4 cases out of the 14 died
within 2 years ofhistological diagnosis. In Group 2, 5 out ofthe 7 cases died within
18 months ofdiagnosis. In Group 3 (showing greatest variation in cell size), 3 out
of4 cases died within 10 months. It is thus seen that the greater the variation in
cell size, the shorter is the survival period.
IV. Cellular morphology.
The majority of sections show a mixed picture of round cells and spindle cells
(Fig. 3). Care must be taken in deciding the shape ofthe cell, as a spindle cell cut
transversely may be mistaken for a round cell. The best way of avoiding thisSARCOMA OF THE UTERUS 349
error is to determine the shape of the cell in relationship to a longitudinal section
of a blood-vessel (Novak and Anderson, 1937).
The results were grouped according to the percentage ofround cells and spindle
cells per field. The final figure "per field" was reached by taking the average
percentages after complete study ofthe available sections as described above:
Group 1: Less than 32 per cent of round cells per field.
Group 2: 33 to 65 per cent of round cells per field.
Group 3: 66 per cent and over round cells per field.
The percentage of spindle cells per field were grouped in a similar manner.
Tabulated results show that the percentage of spindle cells in each group and
their survival period are practically the exact opposite of that found in the case
ofround cells. Therefore, a detailed table is shown for round cells only (Table VI).
TABLE VI.
Group 1. Group 2. Group 3.
14 years A &W . 2 years D . 10 months D
13 ,, ,, . 9 months ,, . 2 ,
12 . .... 9 ., , .. 1 ,,
11 ,, ,, . 6 . ...
11 ,, ,, . 4 ,, ,, . 3 cases
9 , ..
8 ,, ,, . 5 cases
8 ,
7 ,
7 ,
3
3,
1
18 months D
7 ,
3 ,.
1 ,.
17 cases
In Group 1, 4 ofthe 17 cases died within 18 months of diagnosis. In Group 2, all
5 cases were dead within 2 years, 3 ofthem within 9 months of diagnosis. In Group
3, all cases were dead within 10 months of diagnosis. The greater the proportion
ofround cells, the worse the prognosis, and conversely, the more spindle cells the
better the prognosis.
V. Presence ofgiant cells.
All giant cells seen were taken into account in the final result, including
multinucleated ones and cells with giant nuclei. Very few giant cells showed
mitotic nuclei. The cases were grouped as follows:
Group I : 0 to 32 per cent of cells per field that were giant cells.
Group 2: 33 to 65 per cent of cells per field that were giant cells.
Group 3: 66 per cent and over of cells per field that were giant cells.
The results based on the number of giant cells present showed no correlation
with the length of survival.350 W. JONES WILLIAMS AND G. BANCROFT-LIVINGSTON
VI. Mitosis.
The sections were examined and the number ofall mitoses per field determined
and grouped as follows:
Group 1: Less than 1 mitosis per 5 fields.
Group 2: More than 1 mitosis per 5 fields and less than 2 mitoses per field.
Group 3: 2 or more mitoses per field.
The range was 1 mitosis in 30 fields up to 8 per field. The results are expressed in
Table VII.
TABLE VII.-Length ofSurvival and Number of Cases in each Group.
Group 1.
14 years A &W
13 . ..
12 . ..
11 ..
9 ,. ..
8 ,
8 1~
3 3~ 3 ,,
10 cases
Group 2.
11 years A &W
7 , .
1 ,,
2,, D
18 months ,,
10 , . .
9 ,, ,,
9 ,, ,,
7 , ..
6 ,, ..
4 , .
3 , .
12 cases
Group 3.
2 months D
1 ,. ..1
1 .9 ..3 3
3 cases
In Group 1 all cases were alive and well when last seen, up to 14 years after
diagnosis. In Group 2, 9 cases out ofthe 12 have died within 2 years ofdiagnosis.
In Group 3, all 3 cases died within 2 months of diagnosis. These results are in
accordance with other workers (Evans, 1920), showing that the greater the number
of mitoses, the worse is the prognosis.
VII. Hyperchromatism.
The sections were examined as stated in the introductory paragraph, and the
number ofhyperchromatic nuclei per field recorded.
Group 1: 0 to 32 per cent of nuclei per field showing hyperchromatism.
Group 2: 33 to 65 per cent of nuclei per field showing hyperchromatism.
(Fig. 4).
Group 3: 66per cent and overof nucleiperfieldshowinghyperchromatism.
TABLE VIII.-Length ofSurvival and Number of Cases in each Group.
Group 1.
14 years A & W
13 ...
12 ...
11 ...
11 ,...
9 ,, ..
8 1, Il
3
,, ,,
2 ,, D
10 cases
Group 2.
8 years A & W
7 , .
7 ,.,.
1,, I ,.1 ..
18 months D
9 ,,
7 , .
6 ,. ..
3 , .
I 1 1 c as
11 cases
Group 3.
10 months D
9 ,,
4a ,,
2 ,. .
4 casesSARCOMA OF THE UTERUS
In Group 1 (the least number of hyperchlromatic nuclei), 1 case out of the 10 died
within 2 years of diagnosis. In Group 2 (intermnediate group), 7 out ofthe 11 cases
died within 18 months of diagnosis. In Group 3 (the highest number of hyper-
chromatic nuclei), all 4 cases died within 10 months of diagnosis. It is thus seen
that the higher the proportion of hyperchromatic nuclei, the shorter becomes the
survival period.
VIII. Site of origin.
Table IX shows the distribution of cases as to their site of origin.
TABLE IX.
Site of origin. Number of cases.
Leiomyoma . . . 20
Endometrium . . I (lefinite
4 "probables"
Myometrium . . 0
Blood-vessels . . . 0
The majority ofcases arose on a fibroid basis (Fig. 5). In only 1 case was it thought
that the tumour had definitely arisen outside a fibroid, from the endometrium.
Macroscopically this tumour replaced the entire endometrium and was of soft
and bulky consistency, with infiltration into the myometrium in some areas.
Microscopically there was no evidence ofany previous fibroid basis for the tumour.
The tumour was highly cellular, with a minimum amount of stroma. The case
showed blood-vessel invasion, and death occurred within 9 months of diagnosis.
The 4 "probable" cases arising from the endometrium showed no related fibroid,
but the picture in some areas suggested that they may have arisen from a fibroid.
It is of interest to record that 3 out of these 4 cases died within 1 month, 2
months and 10 months ofdiagnosis; the fourth case was alive and well when last
seen, 9 years after the initial diagnosis.
Treatment.
Both surgery and radiotherapy as the basic form of treatment have their
advocates. and there are those who place their faith in some combination of the
two (Crossen and Crossen, 1941; Cooke, 1943; White, 1949).
The published series ofcases are all smniall, and it is difficult to get any impression
of the efficacy of treatment fromn a study of the figures. As we see it, the problem
is twofold:
I. The treatment to be adopted when the diagnosis is made pre-operatively
or at operation.
II. Treatment of those cases in whom the diagnosis has been made in the
laboratory:
(a) Following complete uterine removal.
(b) Following myomectomy or subtotal hysterectomy.
1. In those cases where the correct pre-operative diagnosis has been made,
radical hysterectomy is probably the treatment of choice (Browne, 1950). The
problem at issue in these cases is whether pre- and/or post-operative deep X-ray
therapy should be employed Opinions differ markedly on the point. Perry (1948)
maintains that deep X-ray therapy is of little value, and is supported in this view
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by Bosse and Stanton (1943). At the Radiumhemmet, Heyman (1950) does not
consider that preliminary radiotherapy is indicated, and only advises post-
operative irradiation when sarcomatous tissue has been found in the edge of the
removed specimen. Randall (1943) believes that in cases of endometrial sarcoma
diagnosed on curettage, preliminary intracavity radium followed by radical
surgery may be the treatment of choice. The type of hysterectomy performed is
probably not important, but most authorities advocate a wide pelvic clearance,
omitting, however, glandular dissection. It is a matter for regret that a correct
pre-operative diagnosis is seldom made. Our findings indicate, however, that the
prognosis depends far more upon the degree ofmalignancy ofthe growth than upon
the nature of the treatment.
II. The more difficult, though numerically more numerous, group is that in
which the diagnosis is made in the pathological laboratory.
If initial surgical removal has been complete, there is nothing further that
can be done, apart from a course of deep X-rays of doubtful value, whatever the
nature of the growth. If, however, the removal has been incomplete (subtotal
hysterectomy or myomectomy), further surgical treatment might be planned,
bearing in mind the accurate prognosis that we have shown can be provided by
complete pathological assessment. It is along these lines we suggest that the
prognosis will be improved in this condition.
TABLE X.-Treatment and Survival.
Treatment. Number of Alive. Died. cases.
Complete removal of uterus with or 12 . 7 . 5
without adnexal removal (from 1-14 years (from 1-18 months
after operation) after operation)
Complete removal and deep X-ray 2 . 1 . 1
(9 years after (within 2 years)
operation)
Subtotal hysterectomy alone . . 5 . 3 . 2
(from 7-12 years (from 4-9 months
after operation) after operation)
Subtotal hysterectomy and deep X-ray 5 . 2 . 3
(11 years aftel (between 1 and 10
operation) months after operation)
Deep X-ray only . . . 1 . 0 . 1
(within 3 months)
Complications and Spread.
In those of our cases examined post-mortem, local recurrences, peritoneal
spread, pulmonary and cerebral metastases have been found. We have not
encountered deposits in bones, as recorded by Brooke and Thomason (1945), or in
the kidneys and intestines (Browne, 1950). Regardless ofthe method oftreatment,
9 of our 26 cases (36 per cent) were dead within a year, and a further 3 within 2
years. Ten ofour cases are known to have survived 5 years (40 per cent), a figure
that compares favourably with those reported in the literature (Kimbrough, 1934;
Novak and Anderson, 1937; Randall, 1943). Cooke (1943) was only able to report
10 to 14 per cent five-year survival.
DISCUSSION.
It will be seen from our results that a classification of uterine sarcomata based
on the relationship of tumour to blood-vessels distinguishes the highly malignant
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cases from those of lesser malignanvcy. Every case showing such a relationship
died within a period of 18 months following diagnosis.
Thedegree ofvariation incell size bears adefiniterelationship to survivaltime:
the greater the variation, the worse the prognosis. This feature is difficult to
evaluate numerically, so that the results will tend to vary with the individual
observer. This detracts from its value, but nevertheless from the comparison of a
number ofcases one can gain a definite impression ofthe degree ofvariation in cell
size which is ofprognostic significance.
Cellular morphology is ofvalue in assessing malignancy. Our results show that
the greater the proportion of round cells to spindle cells the worse the prognosis.
It would appear, from our results, that more than 33 per cent of round cells per
field carries a much graver prognosis than a value below this figure. All our cases
with more than 33 per cent of round cells per field died within a period of 2 years
fo]lowing diagnosis; indeed all but one case died within 10 months. The corollary
holds for spindle cells, as the higher the proportion ofspindle cells, the better the
prognosis. These results are in accordance with those of other workers (Kim-
brough, 1934).
The degree of cellularity of uterine sarcoma has proved to be of no value in
assessing prognosis. This point is easily understood, as the proportion of cells to
stroma is extremely difficult to assess with any accuracy.
The presence ofgiant cells in these tumours showed no correlation with survival
time. We agree with Evans (1920) that giant cells are more likely to be associated
with degeneration than with the rate ofgrowth. This is borne out by the fact that
very few of these giant-cell nuclei show mitotic figures.
The number ofmitoses present serves as a sound prognostic index. Our results
show that less than 1 mitosis per 5 fields carries a good prognosis; all in this group
were alive and well from 3 to 14 years following diagnosis, this being the range of
theirfollow-up period. In those exhibiting more than 1 mitosisper 5 fields and less
than 2 mitoses per field, 75 per cent died within 2 years ofdiagnosis and all with
more than 2 mitoses per field died within 2 months ofdiagnosis. It would appear
that there is a "critical level" of 1 mitosis in 5 fields. The greater the number of
mitoses per field above this level the worse theprognosis. Our results bear out the
excellent work done by Evans (1920) on mitotic counts, though we have used a
simpler estimation, obviating the counting of mitotic nuclei per cubic millimetre.
It should be noted that all mitoses were counted, whether normal or abnormal
(Fig. 4).
Nuclear hyperchromatism is of value in assessing prognosis. The higher the
percentage of hyperchromatic nuclei the worse the prognosis. All our cases with
more than 66 per cent ofhyperchromatic nuclei per field died within 10 months of
diagnosis, while only 1 with less than 32per cent diedduring thefollow-up period.
As regards the site of origin ofthese tumours, our figures suggest that those of
endometrial origin carry a worse prognosis than those arising in a previous
leiomyoma, but our cases of extra fibroid origin are too few to warrant a definite
conclusion. These results are in agreement with those ofprevious workers. There
is often considerable difficulty in determining the exact site oforigin, as a rapidly
growing sarcoma arising in a fibroid may destroy the original pattern and lead one
to a mistaken diagnosis of " myometrial sarcoma" or "endometrial sarcoma".
In the present state of our knowledge the rational treatment of this condition
would seem to be radical surgical removal. Both pre- and post-operative X-ray
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therapy are of doubtful value only. In those cases in which the removal has not
been radical (myomectomy or subtotal hysterectomy), we suggest that further
treatment should be basedupon acareful assessment oftheprognosis bythemethod
discussed above. It is only by such an approach to the problem that an occasional
further case can be saved.
SUMMARY.
Twenty-five cases of uterine sarcoma occurring in a twenty-year period are
presented, and the following histological features are found to be of value in
assessing prognosis:
(1) Relation of tumour to blood vessels.
(2) Variation in cell size.
(3) Cellular morphology.
(4) Number of mitoses;
(5) Nuclear hyperchromatism.
(6) Site of origin of the tumours.
The degree of cellularity and the percentage of giant cells were of no value in
assessing prognosis.
If the diagnosis is suspected either before or during operation, radical pelvic
clearance would seem to offer the best prognosis, although it must be realised
that the ultimate chance of survival rests upon the degree of malignancy as
demonstrated by carefuil pathological assessment.
If the diagnosis is unsuspected and the surgery has been incomplete, we feel
that furthertreatment should be based on a careful consideration ofthe histological
nature of the growth and the prognosis resulting from this.
Our thanks are due to the consultant gynaecological staff of the Middlesex
Hospital and the Hospital for Women, Soho, under whose care these cases were
treated, for permission to record them, to Professor R. W. Scarff for access
to the material, and to Professor J. Gough for much helpful advice and criticism.
We are indebted to Mr.4. P. Napper for assistance with the photomicrographs,
and to Mr. E. C. Clayden for the histological preparations.
The statistical analysis was kindly undertaken by Dr. E. Lewis Fanning.
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